
Stryker Corporation remains a global leader in medical technologies, with strong segment breadth and robust product innovation. Read more on SYK stock here.
SYK is down 0.33% today. Volume is 1.89M vs a 30-day average of 2.69M (0.70x).
Stryker Corporation is scheduled to report earnings Thu, Oct 29, 2026 · after close. Analysts expect EPS of $3.58 on revenue of about $6.69B. Stocks often move sharply on earnings day.

Stryker Corporation remains a global leader in medical technologies, with strong segment breadth and robust product innovation. Read more on SYK stock here.

Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining…

Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker has completed its acquisition of ZuriMED, adding the FiberLocker System to its Sports Medicine portfolioThe acquisitio…

Stryker (SYK) just received 510(k) clearance from the U.S. Food and Drug Administration for Sonopet 3, a new ultrasonic bone and soft tissue removal platform shaped by extensive s…

Stryker has had a mixed run, with the share price up 22.3% over three years but still showing declines over the past year. This puts fresh focus on whether the current US$307.08 l…